PATENT CLAIM ANALYSIS

Application Number: 15903851
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to novel amino acid sequences of peptides derived from HPV 16 that are able to bind to MHC complexes of class II, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.

Claim (Index 5):
A pharmaceutical composition comprising the peptide according to  claim 1 , and optionally at least one additional peptide consisting of an amino acid sequence selected from the group of SEQ ID NOs: 26, 9, 7, and 18.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.29268
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15104165', '12451983', '15678970', '14453286', '10433936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7477864615625222
- 35 USC 102 Novelty (BERT): 0.6139456284868071
- Combined Prediction Score: 0.7344023782549507
- Mean Citation Score: 451.469304
- Max Citation Score: 601.5992
- Similarity Product: 472.0111940715313

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test